Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Diseases × Acetaminophen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain 14 Multiple Myeloma 12 Pain, Postoperative 10 Neoplasms 9 Agnosia 8 Lymphoma, Non-Hodgkin 6 Lung Neoplasms 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Cancer Pain 5 Breast Neoplasms 5 Neoplasm Metastasis 4 Lymphoma 4 Leukemia 4 Hodgkin Disease 4 Head and Neck Neoplasms 4 Prostatic Neoplasms 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Lymphoma, B-Cell 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Leukemia, Hairy Cell 3 Hematologic Neoplasms 3 Colonic Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Burkitt Lymphoma 3 Trigger Finger Disorder 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Philadelphia Chromosome 2 Myelodysplastic Syndromes 2 Melanoma 2 Lymphoma, Mantle-Cell 2

Interventions

Trastuzumab 7 Letrozole 7 Anastrozole 7 palbociclib 6 exemestane 6 Docetaxel 6 Fulvestrant 5 ribociclib 4 pyrotinib 4 entinostat 4 abemaciclib 4 Cyclophosphamide 4 Doxorubicin 3 pertuzumab 2 Sodium Chloride 2 Paclitaxel 2 Lapatinib 2 Gonadotropin-Releasing Hormone 2 Exercise 2 Everolimus 2 Epirubicin 2 Drug Evaluation 2 Capecitabine 2 Botulinum Toxins, Type A 2 Blood Specimen Collection 2 Aromatase Inhibitors 2 AZD9833 2 tucatinib 1 trastuzumab deruxtecan 1 taxane 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00299039 2009-02-02

T3AI

Nova Scotia Health Authority

Phase 3 Completed

Agnosia, Breast Diseases, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡